Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 1.00 |
| ▸ | LMNA | P02545 | 2/20 | 0.51 |
| ▸ | AKT1 | P31749 | 2/20 | 0.51 |
| ▸ | ESR1 | P03372 | 1/20 | 0.51 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.51 |
| ▸ | CDC25A | P30304 | 1/20 | 0.51 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.51 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.51 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.51 |
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.50 |
| ▸ | PRKCG | P05129 | 1/20 | 0.50 |
| ▸ | PRKCB | P05771 | 1/20 | 0.50 |
| ▸ | PRKCA | P17252 | 1/20 | 0.50 |
| ▸ | PRKCH | P24723 | 1/20 | 0.50 |
| ▸ | PRKCI | P41743 | 1/20 | 0.50 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.50 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.50 |
| ▸ | PRKCZ | Q05513 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL245306 | 1.00 | SMN1; SMN2 (1.00) | SMN1; SMN2LMNAAKT1ESR1ADORA3 | |
| SCHEMBL272506 | 1.00 | SMN1; SMN2 (1.00) | SMN1; SMN2LMNAAKT1ESR1ADORA3 | |
| Hydrogen Peroxide SCHEMBL15769657 | 0.98 | SMN1; SMN2 (0.97) | SMN1; SMN2LMNAAKT1ESR1ADORA3 | |
| Methylamine SCHEMBL9699690 | 0.97 | SMN1; SMN2 (0.94) | SMN1; SMN2LMNAAKT1ESR1ADORA3 | |
| SCHEMBL10586725 | 0.87 | SMN1; SMN2 (0.76) | SMN1; SMN2LMNAAKT1ESR1ADORA3 | |
| SCHEMBL28965396 | 0.85 | SMN1; SMN2 (0.73) | SMN1; SMN2LMNAAKT1ESR1ADORA3 | |
| SCHEMBL23199737 | 0.83 | SMN1; SMN2 (0.71) | SMN1; SMN2LMNAAKT1ESR1ADORA3 | |
| SCHEMBL19821621 | 0.83 | SMN1; SMN2 (0.71) | SMN1; SMN2LMNAAKT1ESR1ADORA3 | |
| SCHEMBL4989896 | 0.83 | SMN1; SMN2 (0.70) | SMN1; SMN2LMNAAKT1ESR1ADORA3 | |
| SCHEMBL1853865 | 0.83 | SMN1; SMN2 (0.70) | SMN1; SMN2LMNAAKT1ESR1ADORA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 7630 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260144836-A1 | NUTRACEUTICAL FOR ENHANCED COGNITIVE PERFORMANCE | Herbanized Wellness, LLC (US) | 2026-05-28 | — | — | US | claimed |
| EP-4746864-A1 | C5 KETONE COMPOSITIONS AND RELATED METHODS FOR TREATING METABOLIC DYSFUNCTION | Keto Innovations, LLC (US) | 2026-05-27 | — | — | EP | claimed |
| EP-4747627-A1 | METHODS AND SYSTEMS FOR PREDICTIVE CLASSIFICATION BY MASS SPECTROMETRY AND TRAINED LARGE SPECTRAL MODELS | Matterworks Inc (US) | 2026-05-27 | — | — | EP | claimed |
| CN-122081073-A | Excrement fungus cryopreservation liquid and application thereof | — | 2026-05-26 | — | — | CN | claimed |
| WO-2026106498-A1 | PERFUSION FLUID, METHODS OF PRODUCING PERFUSION FLUID, AND ITS USES | NanoSanguis S.A. (PL) | 2026-05-21 | — | — | WO | claimed |
| EP-4744486-A1 | PERFUSION FLUID, METHODS OF PRODUCING PERFUSION FLUID, AND ITS USES. | NanoSanguis S.A. (PL) | 2026-05-20 | — | — | EP | claimed |
| EP-4743094-A1 | LIPOSOMAL FORMULATIONS OF CORTICOSTEROIDS AND USES THEREOF | Eden Ophthalmic Pte Ltd. (SG) | 2026-05-20 | — | — | EP | claimed |
| EP-4744487-A1 | FLUID, METHODS OF PRODUCING FLUID, AND ITS USES | NanoSanguis S.A. (PL) | 2026-05-20 | — | — | EP | claimed |
| CN-122056386-A | Moisture absorption resistant slow release microcapsule powder and preparation method and application thereof | 大连医诺生物股份有限公司 | 2026-05-19 | — | — | CN | claimed |
| CN-121673250-B | Polyamino cationic lipids containing carbamate structures, compositions comprising same and uses | 北京悦康科创医药科技股份有限公司 | 2026-05-15 | — | — | CN | claimed |
| EP-0201623-B1 | PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF INVOLUTIONAL BRIAN SYNDROMES AND MENTAL DECAY | LPB Istituto Farmaceutico s.p.a. (IT) | 1990-02-07 | — | — | EP | claimed |
| WO-1989009600-A1 | METHOD AND COMPOSITION FOR TREATING NEUROLOGICAL DISORDERS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 1989-10-19 | — | — | WO | claimed |
| US-4792599-A | Biocompatible polyesters | BIOCOMPATIBLES LTD. (GB) | 1988-12-20 | — | — | US | claimed |
| EP-0275293-A1 | POLYESTERS. | BIOCOMPATIBLES LTD (GB) | 1988-07-27 | — | — | EP | claimed |
| WO-1988000956-A1 | POLYESTERS | BIOCOMPATIBLES LIMITED (GB) | 1988-02-11 | — | — | WO | claimed |
| EP-0217258-A2 | The use of choline or choline releasing compounds in the production of pharmacological compositions capable of reducing fatigue | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 1987-04-08 | — | — | EP | claimed |
| EP-0217765-A2 | Process for the preparation of L-alpha-glycerylphosphorylcholine, L-alpha-glycerylphosphorylethanolamine from crude and/or deoleated lecithins | ISTITUTO CHEMIOTERAPICO ITALIANO FINE CHEMICALS S.p.A. (IT) | 1987-04-08 | — | — | EP | claimed |
| US-4626527-A | REDUCING FATIQUE FROM MAJOR EXERCISE | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 1986-12-02 | — | — | US | claimed |
| US-4624946-A | A-GLYCERYLPHOSPHORYLCHOLINE | LPB ISTITUTO FARMACEUTICO S.P.A. (IT) | 1986-11-25 | — | — | US | claimed |
| EP-0201623-A1 | Pharmaceutical compositions for the treatment of involutional brian syndromes and mental decay | LPB Istituto Farmaceutico s.p.a. (IT) | 1986-11-20 | — | — | EP | claimed |